GMP Plasmid DNA Market
GMP plasmid DNA, or GMP Grade Plasmid DNA can be used for direct injection as DNA vaccines, gene ... Read More
Plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases. Based on classification, Plasmid DNA segment into High Quality Grade, Plasmid DNA, GMP Grade Plasmid DNA and Non-GMP Grade Plasmid DNA.
This report contains market size and forecasts of Plasmid DNA Manufacturing in Global, including the following market information:
Global Plasmid DNA Manufacturing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Plasmid DNA Manufacturing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
HQ Grade Plasmid DNA Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Plasmid DNA Manufacturing include Cobra Bio, Richter-Helm, Eurogentec, Cell and Gene Therapy Catapult, VGXI, PlasmidFactory, Kaneka Corporation, Nature Technology Corporation and Waisman Biomanufacturing, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Plasmid DNA Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Plasmid DNA Manufacturing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Plasmid DNA Manufacturing Market Segment Percentages, by Type, 2021 (%)
HQ Grade Plasmid DNA
GMP Grade Plasmid DNA
Non-GMP Grade Plasmid DNA
Global Plasmid DNA Manufacturing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Plasmid DNA Manufacturing Market Segment Percentages, by Application, 2021 (%)
Cancers
Inherited Disorders
Viral Infections
Others
Global Plasmid DNA Manufacturing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Plasmid DNA Manufacturing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Plasmid DNA Manufacturing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Plasmid DNA Manufacturing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cobra Bio
Richter-Helm
Eurogentec
Cell and Gene Therapy Catapult
VGXI
PlasmidFactory
Kaneka Corporation
Nature Technology Corporation
Waisman Biomanufacturing
FUJIFILM Diosynth Biotechnologies
LakePharma
GMP plasmid DNA, or GMP Grade Plasmid DNA can be used for direct injection as DNA vaccines, gene ... Read More
Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any ... Read More
Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any ... Read More
Beta-glucans are found in the cell walls of a wide range of prokaryotic and eukaryotic organisms, ... Read More